Literature DB >> 31581313

Inactivation of the glutathione peroxidase GPx4 by the ferroptosis-inducing molecule RSL3 requires the adaptor protein 14-3-3ε.

Ana-Marija Vučković1, Valentina Bosello Travain1, Luciana Bordin1, Giorgio Cozza1, Giovanni Miotto1, Monica Rossetto1, Stefano Toppo1, Rina Venerando1, Mattia Zaccarin1, Matilde Maiorino1, Fulvio Ursini1, Antonella Roveri1.   

Abstract

Ras-selective lethal small molecule 3 (RSL3), a drug candidate prototype for cancer chemotherapy, triggers ferroptosis by inactivating the glutathione peroxidase glutathione peroxidase 4 (GPx4). Here, we report the purification of the protein indispensable for GPx4 inactivation by RSL3. Mass spectrometric analysis identified 14-3-3 isoforms as candidates, and recombinant human 14-3-3ε confirms the identification. The function of 14-3-3ε is redox-regulated. Moreover, overexpression or silencing of the gene coding for 14-3-3ε consistently controls the inactivation of GPx4 by RSL3. The interaction of GPx4 with a redox-regulated adaptor protein operating in cell signaling further contributes to frame it within redox-regulated pathways of cell survival and death and opens new therapeutic perspectives.
© 2019 Federation of European Biochemical Societies.

Entities:  

Keywords:  14-3-3 proteins; RSL3; ferroptosis; glutathione peroxidase 4; protein; protein interaction; redox regulation

Year:  2019        PMID: 31581313     DOI: 10.1002/1873-3468.13631

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  14 in total

Review 1.  Organelle-specific regulation of ferroptosis.

Authors:  Xin Chen; Rui Kang; Guido Kroemer; Daolin Tang
Journal:  Cell Death Differ       Date:  2021-08-31       Impact factor: 12.067

2.  Genetic Disruption of the γ-Glutamylcysteine Ligase in PDAC Cells Induces Ferroptosis-Independent Cell Death In Vitro without Affecting In Vivo Tumor Growth.

Authors:  Boutaina Daher; Willian Meira; Jerome Durivault; Celia Gotorbe; Jacques Pouyssegur; Milica Vucetic
Journal:  Cancers (Basel)       Date:  2022-06-28       Impact factor: 6.575

Review 3.  Post-Translational Modification of GPX4 is a Promising Target for Treating Ferroptosis-Related Diseases.

Authors:  Can Cui; Fei Yang; Qian Li
Journal:  Front Mol Biosci       Date:  2022-05-12

Review 4.  Mechanism of Ferroptosis and Its Relationships With Other Types of Programmed Cell Death: Insights for Potential Interventions After Intracerebral Hemorrhage.

Authors:  Sheng-Yu Zhou; Guo-Zhen Cui; Xiu-Li Yan; Xu Wang; Yang Qu; Zhen-Ni Guo; Hang Jin
Journal:  Front Neurosci       Date:  2020-11-13       Impact factor: 4.677

Review 5.  Ferroptosis Mechanisms Involved in Neurodegenerative Diseases.

Authors:  Cadiele Oliana Reichert; Fábio Alessandro de Freitas; Juliana Sampaio-Silva; Leonardo Rokita-Rosa; Priscila de Lima Barros; Debora Levy; Sérgio Paulo Bydlowski
Journal:  Int J Mol Sci       Date:  2020-11-20       Impact factor: 5.923

Review 6.  Heme Oxygenase-1 Signaling and Redox Homeostasis in Physiopathological Conditions.

Authors:  Valeria Consoli; Valeria Sorrenti; Salvo Grosso; Luca Vanella
Journal:  Biomolecules       Date:  2021-04-16

Review 7.  Ferroptosis: A New Regulatory Mechanism in Osteoporosis.

Authors:  Pan Liu; Wenzhao Wang; Zheng Li; Yao Li; Xiaoping Yu; Ji Tu; Zhengdong Zhang
Journal:  Oxid Med Cell Longev       Date:  2022-01-17       Impact factor: 6.543

8.  Ophiopogonin B induces gastric cancer cell death by blocking the GPX4/xCT-dependent ferroptosis pathway.

Authors:  Liyi Zhang; Chunlei Li; Yuzhan Zhang; Jinwen Zhang; Xiaolei Yang
Journal:  Oncol Lett       Date:  2022-02-01       Impact factor: 2.967

Review 9.  Insight into the Double-Edged Role of Ferroptosis in Disease.

Authors:  Lei Zhang; Ruohan Jia; Huizhen Li; Huarun Yu; Keke Ren; Shuangshuang Jia; Yanzhang Li; Qun Wang
Journal:  Biomolecules       Date:  2021-11-30

Review 10.  Insight into Crosstalk between Ferroptosis and Necroptosis: Novel Therapeutics in Ischemic Stroke.

Authors:  Yue Zhou; Jun Liao; Zhigang Mei; Xun Liu; Jinwen Ge
Journal:  Oxid Med Cell Longev       Date:  2021-06-25       Impact factor: 6.543

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.